ADA Scientific Sessions 2026 Abstract·7 JunType 1 Diabetes Multiancestry Polygenic Score (T1D MAPS) Is a Robust Predictor of Type 1 Diabetes Risk across Diverse PopulationsStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2026 Abstract·7 JunMolecular Risk Scores Enhance Type 2 Diabetes (T2D) Prediction beyond Hemoglobin A1c (HbA1c) and Body Mass Index (BMI) across Diverse Clinical ContextsStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2026 Abstract·6 JunRecessive GWAS Meta-analysis of 1.5M Participants Reveal Genetic Architecture of Type 2 Diabetes and Explain Ancestry-Specific Heterogeneity in Allelic EffectsStudy in peopleMechanismsPaper
ADA Scientific Sessions 2026 Abstract·5 JunTime-to-Event Nonadditive Analysis Identifies Novel Genetic Variants Associated with Treatment Response and Weight Loss in the GRADE Clinical TrialTrial in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunAn eQTL Resource of Insulin Target Tissues from Latin American Participants Reveals Ancestry-Specific Regulatory Mechanisms of Type 2 Diabetes and Lipid TraitsStudy in peopleAI & dataPaper
ADA Scientific Sessions 2025 Abstract·13 JunImproved Polygenic Risk Prediction for Type 2 Diabetes through a GWAS Meta-analysis of over 200,000 Latin American IndividualsStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2025 Abstract·13 JunLarge-Scale Multiancestry Recessive GWAS Meta-analysis Identifies Novel Recessive Associations and Improves Polygenic Prediction of Type 2 DiabetesStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2025 Abstract·13 JunGenetic Variants Associated with Weight Change in Response to Glucose-Lowering Medications—Results from the GRADE StudyTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunLeveraging Rare Variant Association Analyses to Develop Polygenic Risk Scores (PRSs) for Type 2 Diabetes (T2D)Study in peopleBiomarkersPaper